Celltrion's Biosimilar Clinical Evidence Heavily Weighted By Ex-US Data
On FDA's advice, Inflectra sponsor conducted three-way pharmacokinetic bridging study to justify relevance of clinical comparative efficacy data using European version of Remicade.